AzTrials
AzTrials

StressNCT06051071

Home-based Stimulation to Promote Resilience

A study testing Transcranial Direct Current Stimulation (tDCS) in people with Stress, run by Institut Guttmann at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Background: Non-invasive brain stimulation showed to be effective in reduce stress related cognitive and mental-health consequences. Thanks to technological advances these devices are now very easy to use and suitable to hoe-based self-administration. Read more about this study

Who is it for?
Ages 40 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Stress
What is being tested?
Transcranial Direct Current Stimulation (tDCS)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteSpain
Study dates
1 Sep 2023to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • No psychiatric conditions or neurological disorders
  • Do not present any contraindication for their safety in relation to the TDCS protocol (crew metal implants, pacemakers, medical infusion bomb, epilepsy history, brain surgeries, etc.)

Who cannot join

  • alcohol or drug abuse
  • pregnancy

Trial locations and contacts

1 site in 1 country.

Javier Solana-Sanchéz, PhD contact

+34 934 977 700

jsolana@guttmann.com

Gabriele Cattaneo, PhD contact

T. +34 934 977 700

gcattaneo@guttmann.com

Spain1 site, 1 recruiting
  • Guttmann Barcelona

    Barcelona, 08027

    Gabriele Cattaneo, PhD, 673469881, gcattaneo@guttmann.com

    Recruiting

Other trials in Spain

About this study

Official title: Home-based Transcranial Direct Current Stimulation to Modulate Neural Networks and Promote Resilience

Background:

Non-invasive brain stimulation showed to be effective in reduce stress related cognitive and mental-health consequences. Thanks to technological advances these devices are now very easy to use and suitable to hoe-based self-administration.

Read more

Objective:

Conduct a home-based and tele-supervised non-invasive brain stimulation intervention to modulate the expression of resilience brain networks.

Methods:

Transcranial direct current stimulation will be used duringa tele-supervised home-based stimulation intervention to promote the expression of brain resilience networks.

Expected results:

The present project should provide critical new knowledge and evidences of the feasibility and impact of modulating brain resilience networks in terms of its effects on mental health of participants, including the possibility to implement future self-administered, home-based interventions.

Read the detailed description

Resilience, the concept that describes the ability of certain individuals to resist, among others, the impact of stress, is a broad term.

In clinical psychology and mental health, the concept of resilience has historically been linked to the study of individual differences (e.g. self-esteem, sense of control, perception of social support, etc.) that determine the ability to cope with the impact of life traumas and maintain good psychological and physical functioning, avoiding mental illness.

Neuroimaging research has identified brain regions that show patterns of specific activity and connectivity during exposure to stressful or violent stimuli and may be correlated with scores on psychosocial resilience scales or predict coping capabilities.

In the same vein, our group has recently observed how certain connectivity patterns between frontal and parietal areas related to the default neural network (DMN) and pedimental-parietal network (FPN), are predictive of better stress resilience, which decreases the negative impact on mental health.

Together, these findings suggest the possible existence of brain circuits composed of nodes within medial dorsolateral and prefrontal brain areas, and their connections to parietal areas, specifically related to resilience capacity.

In this context non-invasive transcranial stimulation, a safe and effective procedure, provides us with a technique to modulate brain activity in these areas and potentially promote resilience.

Among the various techniques, direct current transcranial stimulation (tDCS) is one of the most studied and promising approaches.

In tDCS, surface electrodes (anode and cathode) inject low-intensity direct current through the skull to modulate brain activity and cortical excitability, with regulatory effects affecting not only areas brains stimulated, but also connected brain networks, and thus with the potential to "optimize" the balance between integration and segregation of associated functions.

Crucially, advances in technology have made tDCS devices more portable and user-friendly, with the possibility of being configured at a distance, and potentially allowing their home administration, with remote supervision, facilitating adherence to intervention protocols.

Goal The aim of this study is to assess the feasibility and effects of a direct intervention to promote resilience to stress

Materials and Method Study Design The researchers will implement an open trial with healthy adults performing a pre-stimulation assessment, a remotely supervised home intervention with tDCS, and a post-treatment assessment.

During the previous assessment, participants will receive training on the use of the stimulation device, as well as information material, and over the course of the intervention, and for the duration of the intervention researchers will remotely monitor the stimulation.

Participants This study will involve 40 healthy adults aged 40 to 65. The sample size has been calculated taking into account the grandor effect of previous studies investigating the modulating effect of non-invasive brain stimulation on functional and behavioral aspects related to resilience, defined as the ability to resist external and stressful factors.

The size of the required sample, considering alpha=0.05 and statistical power (1-beta) =0.80, has been estimated at between 30 and 38 individuals depending on the statistical test. Considering a possible abandonment of around 10%, the final sample will consist of 40 individuals.

Pre-Post Assessment Prior to the intervention, participants will be administered with questionnaires and a paradigm of stress induction.

Once the intervention is complete, the same tests will be repeated.

Stress Induction Paradigm In this task, developed by Limbachia and collaborators there are two circles that move at times by approaching and sometimes moving away from each other. When the circles are touched, the participants receive a soft electrical stressor stimulus. Circular motion has a high degree of unpredictability.

The stressful electric stimulus will be delivered by 500 ms through electrodes, to the fourth and fifth fingers of the left hand. To gauge the intensity of the shock, each participant will be asked to choose their own level of stimulation before the stress task, so that the stimulus is "unpleasant but not painful".

During the task, changes in skin conduction, heart rate, pupil diameter and changes in connectivity and network oscillation reflected by the signal electroencephalography will be recorded.

Feasibility Indicators To confirm the feasibility of such interventions, the investigators will evaluate adherence to intervention.

Stimulation training the researchers will undertake a first training session in person, followed by a training and remote monitoring program. These training sessions will aim to instruct and ensure the correct administration of stimulation.

Stimulation sessions oversight

The researchers will carry out remote monitoring throughout the duration of the intervention:

Investigators will monitor the first 2/3 stimulation sessions, second needs, and until participants need it. From the second week on, researchers will follow the intervention weekly through at least one video call per week.

TDCS stimulation protocol:

The stimulation session will last 20 minutes, following a protocol widely used in various studies.

Stimulation will be performed in the left dorsal lateral prefrontal cortex (L-DLPFC).

The current will be supplied steadily for 30 minutes and all the stimulation parameters to be used adhere to the general guidelines of the safety criteria of transcranial electric stimulation and, for safety reasons, the maximum supplied current will be 2 ma.

The stimulation will be delivered using the Sooma tDCSTM medical device used by health professionals worldwide. This device has acquired CE, Health Canada, MDA, HSA, TGA and COFEPRIS approvals. Sooma tDCSTM devices are manufactured in Finland under ISO 13485 standard.

Conditions
Stress
Being tested
Transcranial Direct Current Stimulation (tDCS)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcranial Direct Current Stimulation (tDCS)Device

    In tDCS, surface electrodes (anode and cathode) inject low-intensity direct current through the skull to modulate brain activity and cortical excitability

Study groups in NCT06051071
Study groupRoleWhat they receive
TreatmentExperimentaltDCS stimulation arm
Receives: Device: Transcranial Direct Current Stimulation (tDCS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in the Connor Davidson resilience scale

    A resilience scale scoring from 0 to 40, where higher score represent better resilience

    Measured: immediately after the intervention

  2. Changes in the State-Trait Anxiety Inventory

    Anxiety scale scoring from 0 to 80 where higher scores indicates greater anxiety

    Measured: immediately after the intervention

  3. Changes in the Holmes stress inventory

    stress scale scoring from 0 to 430 points, where higher scores indicates greater stress

    Measured: immediately after the intervention

  4. Adherence

    number of sessions completed

    Measured: immediately after the intervention

Secondary outcomes (4)
  1. Heart rate variability changes

    Heart rate changes during the task

    Measured: immediately after the intervention

  2. Pupill dilatation changes

    Pupil diameter changes during the task

    Measured: immediately after the intervention

  3. Skin electrical activity changes

    Skin electrical activity changes during the task

    Measured: immediately after the intervention

  4. EEG signal changes

    EEG signal changes during the task

    Measured: immediately after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Sep 2023
  2. Study start1 Sep 2023
  3. Primary completion15 Nov 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06051071
Sponsor's protocol ID
201129-30-31
Status last verified
Sep 2023
First submitted
30 Jun 2023
Last updated
22 Sep 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Transcranial Direct Current Stimulation (tDCS) in people with Stress, run by Institut Guttmann at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Javier Solana-Sanchéz, PhD (+34 934 977 700, jsolana@guttmann.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in the Connor Davidson resilience scale (time frame: immediately after the intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in